Cargando…

Bioengineering of bacteria for cancer immunotherapy

Here, we provide a brief overview of the approaches and strategies underlying bacteria-based cancer immunotherapy (BCiT). We also describe and summarize research in the field of synthetic biology, which aims to regulate bacterial growth and gene expression for immunotherapeutic use. Finally, we disc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nguyen, Dinh-Huy, Chong, Ari, Hong, Yeongjin, Min, Jung-Joon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272223/ https://www.ncbi.nlm.nih.gov/pubmed/37322031 http://dx.doi.org/10.1038/s41467-023-39224-8

Ejemplares similares

Transforming bioengineering with unbiased teams and tools
por: Jewell, Christopher M., et al.
Publicado: (2023)

Digital posters for interactive cellular media and bioengineering education
por: Venkatesan, Mythreye, et al.
Publicado: (2019)

Bioengineering of nano metal-organic frameworks for cancer immunotherapy
por: Chong, Gaowei, et al.
Publicado: (2020)

Optimized Doxycycline-Inducible Gene Expression System for Genetic Programming of Tumor-Targeting Bacteria
por: Nguyen, Dinh-Huy, et al.
Publicado: (2021)

Ferroptosis: a new approach for immunotherapy
por: Zeng, Chong, et al.
Publicado: (2020)

Pattern of F-18 FDG Uptake in Colon Cancer after Bacterial Cancer Therapy Using Engineered Salmonella Typhimurium: A Preliminary In Vivo Study
por: Chong, Ari, et al.
Publicado: (2022)

Cancer immunotherapy comes of age and looks for maturity
por: Finck, Amanda, et al.
Publicado: (2020)

Two contrasting papers stimulate a commentary on the origins of tumour immunology, current cancer immunotherapies, and the future potential for cancer immunotherapy
por: Bodmer, Walter
Publicado: (2022)

Towards evidence-based response criteria for cancer immunotherapy
por: Garralda, Elena, et al.
Publicado: (2023)

Acquired mechanisms of immune escape in cancer following immunotherapy
por: Bryan Iorgulescu, J., et al.
Publicado: (2018)

Potential solutions for manufacture of CAR T cells in cancer immunotherapy
por: Blache, Ulrich, et al.
Publicado: (2022)

COVID-19 vaccination and cancer immunotherapy: should they stick together?
por: Brest, Patrick, et al.
Publicado: (2021)

Precision intervention of cell type-specific targeting is required for future cancer immunotherapy
por: Cai, Yitong, et al.
Publicado: (2023)

T follicular helper and B cell crosstalk in tertiary lymphoid structures and cancer immunotherapy
por: Garaud, Soizic, et al.
Publicado: (2022)

The era of bioengineering: how will this affect the next generation of cancer immunotherapy?
por: Graciotti, Michele, et al.
Publicado: (2017)

Immunotherapy in COVID-19: why, who, and when?
por: Sinha, Pratik, et al.
Publicado: (2021)

Genetic Programming by Nitric Oxide-Sensing Gene Switch System in Tumor-Targeting Bacteria
por: Qin, Yeshan, et al.
Publicado: (2023)

Bioengineering coagulation factors for improved hemophilia treatments(): Comment on: the mutation F309S increases FVIII secretion in human cell line
por: Hounkpe, Bidossessi Wilfried, et al.
Publicado: (2016)

Immunotherapies for COVID-19: lessons learned from sepsis
por: Remy, Kenneth E, et al.
Publicado: (2020)

From macrophage biology to macrophage-based cellular immunotherapies
por: Mass, Elvira, et al.
Publicado: (2021)

Immune-related adverse events and the balancing act of immunotherapy
por: Conroy, Michael, et al.
Publicado: (2022)

Early immunomodulators with CAR T-cell immunotherapy in the COVID-19 era
por: Abid, Muhammad Bilal
Publicado: (2022)

T-lymphoid progenitor-based immunotherapies: clinical perspectives for one and all
por: Gaudeaux, P., et al.
Publicado: (2022)

Immunology Meets Bioengineering: Improving the Effectiveness of Glioblastoma Immunotherapy
por: Fekrirad, Zahra, et al.
Publicado: (2022)

Heterogeneous PD-L1 expression in metastases impacts immunotherapy response
por: Hu, Xiaoqian, et al.
Publicado: (2023)

T-cell tumour exclusion and immunotherapy resistance: a role for CAF targeting
por: Hanley, Christopher J., et al.
Publicado: (2020)

Selection Criteria of Cord Blood Units for Platelet Gel Production: Proposed Directions from Hellenic Cord Blood Bank. Comment on Mallis et al. Short Term Results of Fibrin Gel Obtained from Cord Blood Units: A Preliminary in Vitro Study. Bioengineering 2019, 6, 66
por: Mallis, Panagiotis, et al.
Publicado: (2021)

The global response: how cities and provinces around the globe tackled COVID-19 outbreaks in 2021 – authors’ reply
por: Jain, Nityanand, et al.
Publicado: (2023)

Real world evidence of long-term benefits from allergen-specific immunotherapy (AIT)
por: Scadding, Guy
Publicado: (2021)

Approaches in Immunotherapy, Regenerative Medicine, and Bioengineering for Type 1 Diabetes
por: Kopan, Christopher, et al.
Publicado: (2018)

Use of aerosolised medications at home for COVID-19
por: Ari, Arzu
Publicado: (2020)

Reply to the commentary “Liquid gold: do we need to fraction fresh colostrum for oral immunotherapy in premature infants?”
por: Kazemian, Sina, et al.
Publicado: (2022)

The grace of aging with ART: Ex vivo dendritic cell-based immunotherapy restores HIV-specific functional CD8(+) T-cells
por: Mehraj, Vikram, et al.
Publicado: (2022)

Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours
por: Oosting, Sjoukje F, et al.
Publicado: (2022)

Bioengineering of Bordetella pertussis Adenylate Cyclase Toxin for Antigen-Delivery and Immunotherapy
por: Chenal, Alexandre, et al.
Publicado: (2018)

Bioengineered Ferritin Nanocarriers for Cancer Therapy
por: Sun, Xuanrong, et al.
Publicado: (2021)

Seminal papers in urology: maintenance Bacillus Calmette-Guerin (BCG) immunotherapy for recurrent Ta, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized southwest oncology group study (SWOG-8507)
por: Tempo, Jake, et al.
Publicado: (2023)

Unraveling POLN germline mutations in familial nasopharyngeal carcinoma: Complementary evidence from gene association and molecular studies
por: Chong, Pei Pei
Publicado: (2022)

Bacteria can be selected to help beneficial plasmids spread
por: Dimitriu, Tatiana, et al.
Publicado: (2021)

Improvement studies for equitable and evidence-based innovation: an overview of the ‘IM-SEEN’ model
por: Allen, Luke N., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b396q7ke4n1mmggi3np5lkt31a